DS-5565 + Pregabalin + Placebo tablet + Placebo capsule
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Pain Associated With Fibromyalgia
Conditions
Pain Associated With Fibromyalgia
Trial Timeline
Oct 27, 2014 → Jul 14, 2016
NCT ID
NCT02146430About DS-5565 + Pregabalin + Placebo tablet + Placebo capsule
DS-5565 + Pregabalin + Placebo tablet + Placebo capsule is a phase 3 stage product being developed by Daiichi Sankyo for Pain Associated With Fibromyalgia. The current trial status is completed. This product is registered under clinical trial identifier NCT02146430. Target conditions include Pain Associated With Fibromyalgia.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02187471 | Phase 3 | Completed |
| NCT02187159 | Phase 3 | Completed |
| NCT02146430 | Phase 3 | Completed |
Competing Products
20 competing products in Pain Associated With Fibromyalgia